FIRST EXTENSION - GRANTED
granted
on 25 Sep 2024
Last Applicant/ Owned by
400 Interpace Parkway
Parsippany
NJ
07054
Serial Number
97888337 filed on 14th Apr 2023
Registration Number
N/A
Correspondent Address
Laurence Rickles
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
YOU OWN THE DAY NOT TD
Pharmaceutical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases; medical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases Pharmaceutical products for treatment of neurological diseases
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases; medical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical products for treatment of neurological diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97888337
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.13.21 -
Quadrilaterals that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Sep 2024 | SOU EXTENSION 1 FILED |
| 25th Sep 2024 | SOU EXTENSION 1 GRANTED |
| 25th Sep 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 25th Sep 2024 | SOU TEAS EXTENSION RECEIVED |
| 09th Apr 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 13th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 24th Jan 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 05th Jan 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 05th Jan 2024 | EXAMINER'S AMENDMENT ENTERED |